In the present study, we further revealed that patients with relatively high HTATIP2 expression tended to have a small tumor volume, diminished metastases, and prolonged postoperative survival, and these findings were consistent with those from previously described experimental research and with clinical findings from other tumor types[18, 23]. The gene discussed is HTATIP2; the disease is neoplasm.